Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The chat on twitter suggest early next week...
I agree with your post 100% but Bermudashorts when did reality and a sense of balance ever get in the way of a good ramp eh?
Well said Bermuda.
DDDD is a totally different animal.
GLE
The investment propositions for VAL and DDDD are completely different.
VAL have released initial results from a single arm, open label, dose escalation phase I/IIa study in 12 patients. The objective of any phase I/IIa trial is to look at safety and dosing and early signs of efficacy to establish whether the drug merits further development. VAL's RNS suggests that the safety looks good, there are early signs of efficacy but they haven't yet established the optimum dosing levels. They now will need to run further trials to do this.
4D Pharma's Blautix study is a randomised, blinded phase IIb trial in around 370 patients. I believe that DDDD have confirmed that they intend to license Blautix rather than develop it in-house.
So the 2 drugs are at completely different stages of development and you simply can't make comparisons between a 12 patient phase 1 study and a 370+ patient randomised study in terms of investment proposition. This isn't intended to be at all critical of VAL or its results and of course we still don't know the Blautix results but IMO you can't make any judgement calls about 4D based on what we've seen at VAL. IMO, DYOR etc. etc.
Strange comment to make considering we KNOW news will come in the next few days.
Price is firming up around 1.7 before the next leg up. A close above 1.7 bodes well before news
Expecting news any day now
I have just bought at 170p hope we get some news soon! I feel this going to move up but very nervous. GLA
ok, I may be wrong. I based my little research on VAL based on simply wall (https://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-val/valirx-shares#health) and then management interviews on youtube.
RPSTOCK
you not been doing your home work on VAL
new management and money in the bank and a drug that probably works better than this but I’m in both and fingers crossed
Forget VAL, all that matters is DDDD. If you belive in it, doesn't matter what others have. if like having a missus with DD, why would you look at others! lol
was hoping this would break £2 very quickly. bit disappointed its taking this long... at this rate we have a long way to go. I think the next RNS, could make or break. Lets hope its in our best intrest! GLA
Anyone know how much money val has left ? Any more results to come from them ?
haven't researched much on VAL and it may be good, but I was put off on it in past by seeing balance sheet, past record, management not having very little ownership and management interviews. DDDD is completely opposite (healthy balance sheet with placings in 2020, good pipeline in multiple areas, mgmt having large ownership with money spent recently acquiring more ownership and interviews of its ceo and scientific chief as well as various presentations). I think DDDD, if good results on IBS will go much higher and remain high. If you see 26th Aug oncology result, DDDD went to intraday high of around 1.10, cooled around £1.0 and bit more next day to around 0.94 but then spiked straight to £1.40 and there after step by step it is now near £1.70 with lots more in pipeline.
What's possiblity of dropping this like VAL after the news is announced?
I am fully invested and about 50%up and haven't booked any profit yet.
Here we go traders moving out of VAL and into here. Sold my free carry in them at 66p this morning feel the news has been priced in already. As for 4D well our news will have a far bigger impact on the SP not long to go now folks 400p+ on blockbuster news.
Flying